NIH awards $945 million through NIH HEAL Initiative to reverse opioid crisis

NIH awards $945 million through NIH HEAL Initiative to reverse opioid crisis

Publication date: Sep 27, 2019

To reverse the opioid crisis that continues to grip the nation, the National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative.

The trans-NIH research effort aims to improve treatments for chronic pain, curb the rates of opioid use disorder (OUD) and overdose, and achieve long-term recovery from opioid addiction.

The NIH HEAL Initiative is leveraging expertise from almost every NIH institute and center to approach the crisis from all angles and disciplines, and across the full spectrum of research from basic to implementation science in the areas of: “It’s clear that a multi-pronged scientific approach is needed to reduce the risks of opioids, accelerate development of effective non-opioid therapies for pain and provide more flexible and effective options for treating addiction to opioids,” said NIH Director Francis S. Collins, M. D., Ph. D., who launched the initiative in early 2018.

Scientific solution: Research through the NIH HEAL Initiative will inform treatment guidelines for clinical care of infants who are exposed to opioids in the womb.

“We need to ensure that people with chronic pain have effective treatment options that don’t expose them to the risk of opioids,” said Rebecca G. Baker, Ph. D., director, NIH HEAL Initiative.

Concepts Keywords
Acupuncture Heroin
Addiction Low back pain
Biomarkers Pain management
Brain Opioid use disorder
Chronic Pain Acute pain
Congress President Euphoriants
Cooperative Perception
Emergency Room RTT
Extended Release Morphine
Fiscal Year Opioids
Francis Collins Pain
Hemodialysis Pain management
Heroin Acupuncture
Immunotherapies Immunotherapies
Medicaid Hemodialysis
Medicare Pain management
NIH Back pain
Opioid Addiction
Pain Management
President Trump


Type Source Name
disease MESH low back pain
disease MESH back pain
pathway BSID Release
disease MESH relapse
disease MESH emergency
disease MESH Communities
disease MESH development
disease MESH multi
drug DRUGBANK Tropicamide
disease DOID HHS
disease DOID HHS
drug DRUGBANK Diamorphine
disease MESH opioid addiction
disease MESH chronic pain


Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *